Higher sales helped Johnson & Johnson post a much bigger fourth-quarter profit than a year ago, when a slew of charges depressed results.

However, the company’s 2013 profit forecast, for $5.35 to $5.45 per share, came up short of the average analyst estimate of $5.49.